Monitor for drawdowns under the GEM facility, which would trigger immediate share issuance and dilution. The $85M capacity represents 85% of current market cap, posing significant downside risk if fully utilized. Watch for insider or institutional reactions to this dilution overhang.
Price Chart
Executive Summary
Turn Therapeutics has two effective registration statements (File Nos. 333-290800 and 333-289972) enabling a committed equity financing facility with GEM Global Yield, allowing the company to draw up to $85 million in capital over time. The effectiveness means TTRX can now issue shares to GEM under the previously agreed terms, creating a potential dilution overhang.
Key Facts
- Two EFFECT filings on 2026-04-02 for registration statements 333-290800 and 333-289972
- Registrations relate to a committed equity line with GEM Global Yield for up to $85 million
- Company may issue up to 7,000,000 shares to GEM under the facility
- GEM also received a warrant for 1,192,207 shares at $5.03 exercise price
- Commitment fee of 1% of $85M ($850,000) paid in stock or cash
- No proceeds to company from resale of shares by selling stockholders
Financial Impact
Up to $85 million in potential dilutive capital from equity line; warrant for 1.19M shares; commitment fee of $850,000
Risk Factors
- Significant shareholder dilution if company draws on the full $85M facility
- Potential for continuous downward pressure on stock price as GEM sells acquired shares
- Commitment fee and warrant terms further dilute existing shareholders
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (TTRX) — Batch item 1 | 9999999995-26-001065 |
| Document: 9999999995-26-001065-index.html | 9999999995-26-001062 |
| Document: 9999999995-26-001065.txt | 9999999995-26-001065 |
| EFFECT Filing (TTRX) — Batch item 4 | 9999999995-26-001062 |
| Document: 9999999995-26-001062-index.html | 9999999995-26-001065 |
| Document: 9999999995-26-001062.txt | 9999999995-26-001065 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | DEF 14A | $10.47 | awaiting T+60 | — | $10.41 (−0.57%) |
Oct 6, 2026 20d ago | 8-K | $12.10 | awaiting T+60 | — | $10.41 (−13.97%) |
Sep 10, 2026 6w ago | 8-K | $13.38 | awaiting T+60 | — | $10.41 (−22.20%) |
Sep 9, 2026 6w ago | 8-K | $13.75 | awaiting T+60 | — | $10.41 (−24.29%) |
Aug 18, 2026 10w ago | 8-K | $9.99 | awaiting T+60 | — | $10.41 (+4.20%) |
Jul 7, 2026 16w ago | 8-K | $9.71 $14.39 | ▲ +48.20% | ▲ +46.20% | $10.41 (+7.21%) |
Jun 3, 2026 20w ago | 8-K | $6.02 $10.11 | ▲ +67.94% | ▲ +65.44% | $10.41 (+72.92%) |
Jun 1, 2026 21w ago | 8-K | $6.33 $9.73 | ▲ +53.71% | ▲ +52.48% | $10.41 (+64.45%) |
May 27, 2026 21w ago | 8-K | $5.29 $9.54 | ▲ +80.34% | ▲ +78.46% | $10.41 (+96.79%) |
May 19, 2026 23w ago | 8-K | $4.55 $9.86 | ▲ +116.70% | ▲ +110.41% | $10.41 (+128.79%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers